Ricklie Julian

488 total citations
17 papers, 275 citations indexed

About

Ricklie Julian is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Ricklie Julian has authored 17 papers receiving a total of 275 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 7 papers in Pulmonary and Respiratory Medicine and 3 papers in Surgery. Recurrent topics in Ricklie Julian's work include Lung Cancer Research Studies (6 papers), Lung Cancer Treatments and Mutations (6 papers) and Cancer Immunotherapy and Biomarkers (4 papers). Ricklie Julian is often cited by papers focused on Lung Cancer Research Studies (6 papers), Lung Cancer Treatments and Mutations (6 papers) and Cancer Immunotherapy and Biomarkers (4 papers). Ricklie Julian collaborates with scholars based in United States, Switzerland and China. Ricklie Julian's co-authors include Julie E. Bauman, Malvi Savani, Shuhang Wang, Leena Gandhi, Juergen Wolf, Katherine C. Chretien, Jonathan Keenan, Raya Kheirbek, Rebecca R. Swenson and Nabil F. Saba and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Ricklie Julian

17 papers receiving 273 citations

Peers

Countries citing papers authored by Ricklie Julian

Since Specialization

Citations

This map shows the geographic impact of Ricklie Julian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ricklie Julian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ricklie Julian more than expected).

Fields of papers citing papers by Ricklie Julian

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ricklie Julian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ricklie Julian. The network helps show where Ricklie Julian may publish in the future.

Co-authorship network of co-authors of Ricklie Julian

This figure shows the co-authorship network connecting the top 25 collaborators of Ricklie Julian. A scholar is included among the top collaborators of Ricklie Julian based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ricklie Julian. Ricklie Julian is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

#	Work	Indexed citations
1	Phase II (Alliance A091802) Randomized Trial of Avelumab Plus Cetuximab Versus Avelumab Alone in Advanced Cutaneous Squamous Cell Carcinoma 2025 ·Journal of Clinical Oncology ·Dan P. Zandberg, Jacob B. Allred, Ari J. Rosenberg, John M. Kaczmar, Paul Swiecicki, Ricklie Julian, Andrew Poklepovic, Jessica R. Bauman, Minh D. Phan, Nabil F. Saba, Edgardo Rivera, Kendrith M. Rowland, Diwakar Davar, (unknown), Alan L. Ho, Miao Zhang, Stephanie Berg, Pamela N. Münster, Gary K. Schwartz	1
2	A phase 1 dose-escalation and expansion study of CUE-101, given as monotherapy and in combination with pembrolizumab, in patients with recurrent/metastatic HPV16+ head and neck squamous cell cancer (R/M HNSCC). 2024 ·Journal of Clinical Oncology ·A. Dimitrios Colevas, Christine H. Chung, Douglas R. Adkins, Cristina P. Rodriguez, Jong Chul Park, Michael K. Gibson, Ammar Sukari, Francis P. Worden, Faye M. Johnson, Nabil F. Saba, Barbara Burtness, Ricklie Julian, Julie E. Bauman, Robert M. Jotte, Tanguy Y. Seiwert, Lara Dunn, Marya Chaney, Steven Margossian, Matteo Levisetti, Sara I. Pai	8
3	Abstract CT141: mRNA-4157 (V940) individualized neoantigen therapy (INT) + pembrolizumab (pembro) in advanced unresectable HPV- head & neck carcinoma (HNSCC): Clinical & translational analysis 2024 ·Cancer Research ·Julie E. Bauman, Ricklie Julian, J.L. Geiger, Janice M. Mehnert, Jeffrey Clarke, Manish R. Patel, Martin Gutierrez, Justin F. Gainor, Shyam Srivats, (unknown), (unknown), Vasudha Sehgal, Peijie Hou, (unknown), Igor Feldman, Lakshmi Srinivasan, Praveen Aanur, Michelle Brown, Robert Meehan	3
4	De-Escalation Strategies in HPV-Associated Oropharynx Cancer: A Historical Perspective with Future Direction 2024 ·Cancers ·(unknown), (unknown), Ricklie Julian	1
5	Randomized Phase II Trial of Ficlatuzumab With or Without Cetuximab in Pan-Refractory, Recurrent/Metastatic Head and Neck Cancer 2023 ·Journal of Clinical Oncology ·Julie E. Bauman, Nabil F. Saba, Denise J. Roe, Jessica R. Bauman, John M. Kaczmar, Aarti Bhatia, Jameel Muzaffar, Ricklie Julian, Steven Wang, (unknown), (unknown), Conor Steuer, (unknown), Barbara Burtness, Sara Centuori, Carlos Caulı́n, Robert J. Klein, Kathylynn Saboda, (unknown), Christine H. Chung	25
6	A phase 1 dose-escalation and expansion study of CUE-101, a novel HPV16 E7-pHLA-IL2-Fc fusion protein, given as monotherapy and in combination with pembrolizumab in patients with recurrent/metastatic HPV16+ head and neck cancer. 2023 ·Journal of Clinical Oncology ·Christine H. Chung, A. Dimitrios Colevas, Douglas R. Adkins, Cristina P. Rodriguez, Jong Chul Park, Michael K. Gibson, Barbara Burtness, Faye M. Johnson, Ricklie Julian, Nabil F. Saba, Francis P. Worden, Lara Dunn, Tanguy Y. Seiwert, Robert M. Jotte, Julie E. Bauman, Marya Chaney, Steven Margossian, Matteo Levisetti, Sara I. Pai	7
7	Phase II Trial of CDX-3379 and Cetuximab in Recurrent/Metastatic, HPV-Negative, Cetuximab-Resistant Head and Neck Cancer 2022 ·Cancers ·Julie E. Bauman, Ricklie Julian, Nabil F. Saba, Trisha M. Wise‐Draper, Douglas R. Adkins, Paul E. O’Brien, Mary J. Fidler, Michael K. Gibson, Umamaheswar Duvvuri, Margo Heath‐Chiozzi, Diego Alvarado, Richard Gedrich, (unknown), Roger B. Cohen	8
8	The impact of socioeconomic and geographic factors on access to transoral robotic/endoscopic surgery for early stage oropharyngeal malignancy 2021 ·American Journal of Otolaryngology ·(unknown), (unknown), Jared R. Robbins, Charles C. Hsu, Ricklie Julian, Julie E. Bauman, (unknown), Steven J. Wang, (unknown)	7
9	Randomized phase II trial of ficlatuzumab with or without cetuximab in pan-refractory, advanced head and neck squamous cell carcinoma (HNSCC). 2021 ·Journal of Clinical Oncology ·Julie E. Bauman, Nabil F. Saba, Denise J. Roe, Jessica R. Bauman, John M. Kaczmar, Aarti Bhatia, Jameel Muzaffar, Ricklie Julian, Steven Wang, (unknown), (unknown), Conor Steuer, (unknown), Barbara Burtness, Sara Centuori, Carlos Caulı́n, Kathylynn Saboda, (unknown), Christine H. Chung	3
10	Immunotherapy Approaches in HPV-Associated Head and Neck Cancer 2021 ·Cancers ·Ricklie Julian, Malvi Savani, Julie E. Bauman	36
11	71P A phase II study of ADU-S100 in combination with pembrolizumab in adult patients with PD-L1+ recurrent or metastatic HNSCC: Preliminary safety, efficacy and PK/PD results 2020 ·Annals of Oncology ·Dan P. Zandberg, Robert L. Ferris, Douglas Laux, Ranee Mehra, Lisle M. Nabell, John M. Kaczmar, Michael K. Gibson, (unknown), (unknown), Julie E. Bauman, Ricklie Julian, Douglas R. Adkins, Ezra E.W. Cohen, Barbara Burtness, (unknown), (unknown), (unknown), Angela Loi, (unknown), Nabil F. Saba	23
12	798 Safety, tolerability, and immunogenicity of mRNA-4157 in combination with pembrolizumab in subjects with unresectable solid tumors (KEYNOTE-603): an update 2020 ·SHILAP Revista de lepidopterología ·Julie E. Bauman, Howard A. Burris, Jeffrey Clarke, Manish R. Patel, Daniel Cho, Martin Gutierrez, Ricklie Julian, Aaron J. Scott, Pamela Cohen, Joshua P. Frederick, Céline Robert-Tissot, Haiyu Zhou, (unknown), Karen Keating, Robert Meehan, Justin F. Gainor	49
13	2017–2018 Scientific Advances in Thoracic Oncology: Small Cell Lung Cancer 2019 ·Journal of Thoracic Oncology ·(unknown), (unknown), Shuhang Wang, Ricklie Julian, Leena Gandhi, Juergen Wolf	46
14	Outcomes of advanced pulmonary large cell neuroendocrine carcinoma stratified by RB1 loss, SLFN11 expression, and tumor mutational burden. 2018 ·Journal of Clinical Oncology ·Joshua K. Sabari, Ricklie Julian, Ai Ni, Darragh Halpenny, Matthew D. Hellmann, Alexander Drilon, Bob T. Li, John T. Poirier, Charles M. Rudin, Natasha Rekhtman	11
15	Tell Me Your Story: A Pilot Narrative Medicine Curriculum During the Medicine Clerkship 2015 ·Journal of General Internal Medicine ·Katherine C. Chretien, Rebecca R. Swenson, (unknown), Ricklie Julian, Jonathan Keenan, (unknown), Raya Kheirbek	45
16	Profound Hypereosinophilia Secondary to Sezary Syndrome 2015 ·Blood ·Ardalan Davarifar, Ricklie Julian, (unknown), Emrullah Yilmaz, Amit Verma	1
17	Abstract 3349: Optimizing radioimmunotherapy techniques for the alpha-emitter 225Actinium 2015 ·Cancer Research ·Ricklie Julian, Chi Soo Kang, Xiang Sun, Hyun A. Song, Ekaterina Revskaya, Hyun‐Soon Chong, Ekaterina Dadachova	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact